WuXi and Congress, Boundless Bio, etc.

Stay updated on the latest developments in the biotech industry by signing up for a newsletter. The latest biotech IPO, Boundless Bio, raised $100 million before experiencing a 9% share price drop. Congress is considering legislation that could impact Chinese life sciences companies like WuXi AppTec, which is accused of sharing American intellectual property with Chinese authorities. In other news, Bernie Sanders wants to discuss drug pricing with Novo CEO, the UK releases data on clinical trial sponsors, and Blackstone invests in Moderna. Overall, the biotech industry is experiencing ups and downs but is on track for growth in 2024.

Source link

error: Content is protected !!